Compare GATX & NOVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GATX | NOVT |
|---|---|---|
| Founded | 1898 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Transportation Services | Industrial Machinery/Components |
| Sector | Consumer Discretionary | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.2B | 5.0B |
| IPO Year | 1994 | 1999 |
| Metric | GATX | NOVT |
|---|---|---|
| Price | $178.05 | $146.79 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $215.50 | $144.00 |
| AVG Volume (30 Days) | 149.6K | ★ 281.1K |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | ★ 1.36% | N/A |
| EPS Growth | ★ 17.22 | N/A |
| EPS | ★ 5.19 | 0.82 |
| Revenue | ★ $1,740,400,000.00 | $521,290,000.00 |
| Revenue This Year | $42.21 | $8.61 |
| Revenue Next Year | $3.35 | $6.57 |
| P/E Ratio | ★ $34.12 | $177.76 |
| Revenue Growth | 9.77 | ★ 35.49 |
| 52 Week Low | $150.42 | $98.27 |
| 52 Week High | $205.56 | $176.38 |
| Indicator | GATX | NOVT |
|---|---|---|
| Relative Strength Index (RSI) | 44.40 | 43.76 |
| Support Level | $174.02 | $141.72 |
| Resistance Level | $182.44 | $149.42 |
| Average True Range (ATR) | 3.08 | 4.87 |
| MACD | -0.07 | -0.06 |
| Stochastic Oscillator | 36.14 | 36.11 |
GATX Corp leases transportation assets, including railcars, aircraft spare engines, and tank containers, to customers in North America, Europe, and India. The company's reportable business segments are: Rail North America, Rail International, Engine Leasing, and Other. The majority of its revenue is generated from the Rail North America segment, which is composed of the company's operations in the United States, Canada, and Mexico. This segment mainly provides railcars pursuant to full-service leases under which it maintains the railcars, pays ad valorem taxes and insurance, and provides other ancillary services.
Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.